Ensemble‐based ADME–Tox profiling and virtual screening for the discovery of new inhibitors of the Leishmania mexicana cysteine protease CPB2.8ΔCTE
- 10 November 2017
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 91 (2) , 597-604
Abstract
In an effort to identify novel molecular warheads able to inhibit Leishmania mexicana cysteine protease CPB2.8ΔCTE, fused benzo[b]thiophenes and β,βʹ‐triketones emerged as covalent inhibitors binding the active site cysteine residue. Enzymatic screening showed a moderate‐to‐excellent activity (12%–90% inhibition of the target enzyme at 20 μm). The most promising compounds were selected for further profiling including in vitro cell‐based assays and docking studies. Computational data suggest that benzo[b]thiophenes act immediately as non‐covalent inhibitors and then as irreversible covalent inhibitors, whereas a reversible covalent mechanism emerged for the 1,3,3ʹ‐triketones with a Y‐topology. Based on the predicted physicochemical and ADME–Tox properties, compound 2b has been identified as a new drug‐like, non‐mutagen, non‐carcinogen, and non‐neurotoxic lead candidate.Keywords
This publication has 39 references indexed in Scilit:
- Identification of Semicarbazones, Thiosemicarbazones and Triazine Nitriles as Inhibitors of Leishmania mexicana Cysteine Protease CPBPLOS ONE, 2013
- Phytochemical, Antimicrobial and Antiprotozoal Evaluation of Garcinia Mangostana Pericarp and α-Mangostin, Its Major Xanthone DerivativeMolecules, 2013
- Leishmanicidal, antiproteolytic and antioxidant evaluation of natural biflavonoids isolated from Garcinia brasiliensis and their semisynthetic derivativesEuropean Journal of Medicinal Chemistry, 2012
- Use of cysteine-reactive small molecules in drug discovery for trypanosomal diseaseExpert Opinion on Drug Discovery, 2012
- The resurgence of covalent drugsNature Reviews Drug Discovery, 2011
- α‐Ketoheterocycles as Inhibitors of Leishmania mexicana Cysteine Protease CPBChemMedChem, 2010
- IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand bindingNucleic Acids Research, 2009
- Irreversible Inhibitors of Serine, Cysteine, and Threonine ProteasesChemical Reviews, 2002
- Cysteine protease inhibitors as chemotherapy for parasitic infectionsBioorganic & Medicinal Chemistry, 1999
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973